FDA approves Cimzia to treat Crohn's disease.

Suppr

超能文献

作者信息

Lang Les

出版信息

Gastroenterology. 2008 Jun;134(7):1819. doi: 10.1053/j.gastro.2008.04.034. Epub 2008 May 12.

DOI:10.1053/j.gastro.2008.04.034

PMID:18474249

Abstract

摘要

相似文献

FDA approves Cimzia to treat Crohn's disease.

Gastroenterology. 2008 Jun;134(7):1819. doi: 10.1053/j.gastro.2008.04.034. Epub 2008 May 12.

Certolizumab (Cimzia) for Crohn's disease.赛妥珠单抗（希敏佳）用于治疗克罗恩病。

Med Lett Drugs Ther. 2008 Oct 20;50(1297):81-2.

TNF inhibitors for Crohn's disease: when, which, and for how long.用于克罗恩病的肿瘤坏死因子抑制剂：何时使用、使用哪种以及使用多久。

Med Lett Drugs Ther. 2013 Dec 23;55(1432):102-3.

Drug approvals: '08 in review. Certolizumab pegol (Cimzia).药物批准情况：2008年审查。赛妥珠单抗（希敏佳）。

Nurse Pract. 2009 Feb;34(2):26-7. doi: 10.1097/01.NPR.0000345267.98170.a3.

The classics in perspective.经典之视角

Gut. 2007 Sep;56(9):1184-6. doi: 10.1136/gut.2007.121830.

Certolizumab pegol: a TNF-{alpha} antagonist for the treatment of moderate-to-severe Crohn's disease.注射用培塞利珠单抗：一种用于治疗中重度克罗恩病的 TNF-α拮抗剂。

Ann Pharmacother. 2010 Feb;44(2):333-42. doi: 10.1345/aph.1M314. Epub 2010 Jan 5.

Health outcomes and cost-effectiveness of certolizumab pegol in the treatment of Crohn's disease.聚乙二醇化赛妥珠单抗治疗克罗恩病的健康结局及成本效益

Expert Rev Pharmacoecon Outcomes Res. 2014 Oct;14(5):599-609. doi: 10.1586/14737167.2014.957680.

How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.如何管理难治性克罗恩病：抗TNF药物的最佳给药方式

Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):407-15. doi: 10.1586/egh.09.25.

Remicade approved for children with Crohn's disease.类克获批用于治疗克罗恩病患儿。

FDA Consum. 2006 Jul-Aug;40(4):6.

[Inflammatory bowel diseases--new therapeutic options].[炎症性肠病——新的治疗选择]

Med Klin (Munich). 2008 Feb 15;103(2):90-101; quiz 102-3. doi: 10.1007/s00063-008-1013-3.

引用本文的文献

Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems.炎症性肠病管理的进展：从传统治疗到单克隆抗体及未来的药物递送系统

Pharmaceutics. 2024 Sep 7;16(9):1185. doi: 10.3390/pharmaceutics16091185.

Therapeutic Antibodies in Medicine.医学中的治疗性抗体。

Molecules. 2023 Sep 5;28(18):6438. doi: 10.3390/molecules28186438.

A Comprehensive Review on Steroidal Bioconjugates as Promising Leads in Drug Discovery.甾体生物共轭物作为药物发现中有前景的先导化合物的综合综述。

ACS Bio Med Chem Au. 2022 Mar 23;2(4):340-369. doi: 10.1021/acsbiomedchemau.1c00071. eCollection 2022 Aug 17.

Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy.生物抗 TNF-α 疗法的过去、现在及（可预见的）未来

J Clin Med. 2023 Feb 17;12(4):1630. doi: 10.3390/jcm12041630.

Insights on Development Aspects of Polymeric Nanocarriers: The Translation from Bench to Clinic.聚合物纳米载体的发展现状：从实验室到临床的转化

Polymers (Basel). 2022 Aug 29;14(17):3545. doi: 10.3390/polym14173545.

Evolution of Expression System in Producing Antibody Recombinant Fragments.抗体重组片段表达系统的进化。

Int J Mol Sci. 2020 Aug 31;21(17):6324. doi: 10.3390/ijms21176324.

Molecular Simulations of PEGylated Biomolecules, Liposomes, and Nanoparticles for Drug Delivery Applications.用于药物递送应用的聚乙二醇化生物分子、脂质体和纳米颗粒的分子模拟

Pharmaceutics. 2020 Jun 10;12(6):533. doi: 10.3390/pharmaceutics12060533.

Synthetic Liposomal Mimics of Biological Viruses for the Study of Immune Responses to Infection and Vaccination.合成脂质体模拟生物病毒用于研究感染和疫苗接种的免疫反应。

Bioconjug Chem. 2020 Mar 18;31(3):685-697. doi: 10.1021/acs.bioconjchem.9b00825. Epub 2020 Jan 23.

Quantitation and Stability of Protein Conjugation on Liposomes for Controlled Density of Surface Epitopes.定量和稳定蛋白连接到脂质体上以控制表面表位密度。

Bioconjug Chem. 2018 Apr 18;29(4):1251-1260. doi: 10.1021/acs.bioconjchem.8b00033. Epub 2018 Mar 19.

The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions.治疗性抗体对消化系统疾病管理的影响：历史、当前实践及未来方向

Dig Dis Sci. 2017 Apr;62(4):833-842. doi: 10.1007/s10620-017-4479-0.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验